News

Resumption of prior medical control on expensive prescription drugs from May 2

CNOPS: Resumption of prior medical control on expensive prescription drugs from May 2

Khouloud HASKOURIThursday 21 April 2022 – 02:13

The Moroccan National Fund of Social Security Organizations (CNOPS) “informs pharmacists admitted in third-party payment mode that prior medical control will resume, as of May 2, 2022, on the 119 expensive pharmaceutical drugs covered by the insurance.”

In a press launch obtained shared by MAP this April 20, CNOPS declares that pharmacists should now solely dispense the 119 costly medication coated by the prior authorization of CNOPS issued to the events.

Similarly, the CNOPS restores the prior settlement on costly medication not on the record of 119 medication supported straight beginning the identical date, because it stresses that “the insured must seek prior approval from the CNOPS or other related insurance bodies before acquiring these drugs.”

“CNOPS has taken, as soon as the proclamation of the health exception of COVID-19 in March 2020, an exceptional measure of suspension of prior medical control and direct billing of expensive drugs,” remembers the assertion, noting that this measure has helped to guard insured people, keep away from the unfold of the pandemic, make sure the continuity of advantages and entry of insured individuals to costly medication.

CNOPS Drugs Morocco



Source hyperlink

Leave a Reply

Your email address will not be published.

close